Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
HUMANIGEN, INC (HGEN)
Sector: Healthcare; Industry: Biotechnology

Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. Humanigen, Inc. was founded in 2000 and is based in Burlingame, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-08-12 Chappell Dale Chief Scientific Officer Sell 167,198 $17.10 $2,859,709 No
2021-07-29 Chappell Dale Chief Scientific Officer Sell 39,086 $17.04 $665,866 No
2021-07-14 Chappell Dale Chief Scientific Officer Sell 15,177 $17.06 $258,847 No
2021-07-02 Chappell Dale Chief Scientific Officer Sell 463,096 $17.19 $7,959,379 No
2021-06-25 Chappell Dale Chief Scientific Officer Sell 1,272,655 $17.92 $22,801,514 No
2021-06-14 Durrant Cameron Chief Executive Officer Sell 81,441 $20.64 $1,680,934 No
2021-06-08 Jordan Edward P. Chief Commercial Officer Sell 14,700 $20.08 $295,176 Yes
2021-06-07 Chappell Dale Chief Scientific Officer Sell 80,636 $19.08 $1,538,793 No
2021-06-04 Chappell Dale Chief Scientific Officer Sell 394,364 $18.52 $7,304,993 No
2021-03-09 NOMIS BAY LTD. 10%-Owner Sell 83,568 $17.24 $1,440,495 No
2021-03-11 NOMIS BAY LTD. 10%-Owner Sell 235,238 $16.51 $3,884,756 No
2021-03-01 NOMIS BAY LTD. 10%-Owner Sell 46,505 $19.02 $884,432 No
2021-02-24 NOMIS BAY LTD. 10%-Owner Sell 103,220 $22.29 $2,301,023 No
2021-02-19 NOMIS BAY LTD. 10%-Owner Sell 89,408 $22.25 $1,989,619 No
2021-02-13 NOMIS BAY LTD. 10%-Owner Sell 16,973 $19.72 $334,776 No
2021-02-10 NOMIS BAY LTD. 10%-Owner Sell 54,273 $21.61 $1,172,582 No
2021-02-04 NOMIS BAY LTD. 10%-Owner Sell 73,584 $20.96 $1,542,363 No
2021-01-25 NOMIS BAY LTD. 10%-Owner Sell 95,032 $19.87 $1,888,332 No
2021-01-20 NOMIS BAY LTD. 10%-Owner Sell 8,500 $20.29 $172,423 No
2021-01-19 NOMIS BAY LTD. 10%-Owner Sell 105,000 $18.94 $1,989,020 No
2021-01-12 NOMIS BAY LTD. 10%-Owner Sell 25,000 $18.67 $466,650 No
2020-12-28 NOMIS BAY LTD. 10%-Owner Sell 500 $22.20 $11,101 No
2020-12-22 NOMIS BAY LTD. 10%-Owner Sell 50,000 $20.02 $1,000,985 No
2020-12-24 NOMIS BAY LTD. 10%-Owner Sell 53,401 $21.24 $1,134,104 No
2020-12-22 NOMIS BAY LTD. 10%-Owner Sell 50,000 $50000.00 $2,500,000,000 No
2020-12-21 NOMIS BAY LTD. 10%-Owner Sell 87,700 $16.82 $1,474,766 Yes
2020-08-10 NOMIS BAY LTD. 10%-Owner Sell 17,100 $5.04 $86,098 No
2020-07-28 NOMIS BAY LTD. 10%-Owner Sell 10,000 $5.66 $56,550 No
2020-07-20 NOMIS BAY LTD. 10%-Owner Sell 300,000 $5.00 $1,500,190 No
2020-06-30 NOMIS BAY LTD. 10%-Owner Sell 3,000 $4.91 $14,739 No

Insider Smart

Celldex Therapeutics, Inc. (CLDX) - Multiple insiders including President, EVP, CEO, CSO and Directors bought shares on Jun.9th, first time since 2018, this was very convincing and we initiated a position. Stock soared from $3 to 9$ in 2 days, and the run is still going on.

Insider Smart

Upwork Inc (UPWK) - GRETSCH GREGORY C. Director of Upwork, made a bulk buy of 500K shares right before the big gap up, which is also the largest buy of the past 12 months.